3M Aldara “Approvable” For Basal Cell Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
3M is projecting approval of Aldara for superficial basal cell carcinoma in the second half of 2004 following receipt of an "approvable" letter.
You may also be interested in...
Aldara For Basal Cell Carcinoma
3M's Aldara received a supplemental approval for the treatment of superficial basal cell carcinoma July 14
Aldara For Basal Cell Carcinoma
3M's Aldara received a supplemental approval for the treatment of superficial basal cell carcinoma July 14
Aldara Keratosis Approval
3M's Aldara supplemental NDA cleared FDA March 2 for the treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults